Fecal microbiota transplant in immunocompromised patients: Encouraging results in a vulnarable population

Most read articles by the same author(s)

• Tarkan Karakan, Mustafa KEREM, Mehmet CİNDORUK, Doruk ENGİN, Murat ALPER, Okan AKIN, PPAR-alpha agonist treatment increases trefoil factor family-3 expression and attenuates apoptosis in the liver tissue of bile duct-ligated rats , Turkish Journal of Gastroenterology: Vol. 24 No. 2 (2013): Turkish Journal of Gastroenterology
• Tarkan Karakan, Fecal microbiota transplantation for treating recurrent hepatic encephalopathy: Ready for clinical application? , Turkish Journal of Gastroenterology: Vol. 28 No. 5 (2017): Turkish Journal of Gastroenterology
• Tarkan Karakan, Gut Microbiota and Gastrointestinal Polyps: Unveiling the Causal Connection , Turkish Journal of Gastroenterology: Vol. 36 No. 5 (2025): Turkish Journal of Gastroenterology
• Mehmet CİNDORUK, Tarkan KARAKAN, Management of cervical esophageal strictures with self-expanding metalic stents , Turkish Journal of Gastroenterology: Vol. 17 No. 4 (2006): Turkish Journal of Gastroenterology
• Tarkan Karakan, Long-term antibiotics and PPI’s induce bacterial translocation in patients with cirrhosis: Antibiotics are not always ANTI-biotics , Turkish Journal of Gastroenterology: Vol. 25 No. 4 (2014): Turkish Journal of Gastroenterology
• Tarkan Karakan, Use of Proton Pump Inhibitors and risk of gastric cancer , Turkish Journal of Gastroenterology: Vol. 29 No. 1 (2018): Turkish Journal of Gastroenterology